We are live on
!
Find out more
EFM
E Fund Management Portfolio holdings
AUM
$3.37B
This Fund
S&P 500
This Quarter
Est. Return
+14.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$4.5M
(+0.21%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-8.52%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
429
New
31
Increased
83
Reduced
267
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
abrdn Physical Gold Shares ETF
SGOL
|
+$19.9M |
| 2 |
iShares Gold Trust
IAU
|
+$19.7M |
| 3 |
SPDR Gold MiniShares Trust
GLDM
|
+$19.5M |
| 4 |
SPDR Gold Trust
GLD
|
+$19.5M |
| 5 |
Invesco DB Oil Fund
DBO
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KE Holdings
BEKE
|
+$70.4M |
| 2 |
Futu Holdings
FUTU
|
+$30.9M |
| 3 |
Apple
AAPL
|
+$18.5M |
| 4 |
Microsoft
MSFT
|
+$11.9M |
| 5 |
Applied Materials
AMAT
|
+$9.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.87% |
| 2 | Consumer Discretionary | 23.94% |
| 3 | Communication Services | 11.36% |
| 4 | Healthcare | 5.11% |
| 5 | Financials | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
MannKind Corp
MNKD
$1.28B
| $98K | ﹤0.01% |
26,196
+1,529
| +6% | +$6.74K |
|
377
Anavex Life Sciences
AVXL
$222M
| $94.6K | ﹤0.01% |
10,259
-1,652
| -14% | -$14.1K |
|
378
Arcus Biosciences
RCUS
$3.57B
| $89.4K | ﹤0.01% |
10,987
+489
| +5% | +$4.18K |
|
379
Xencor
XNCR
$1.44B
| $79.3K | ﹤0.01% |
+10,087
| New | +$90.5K |
|
380
ImmunityBio
IBRX
$7.44B
| $74.2K | ﹤0.01% |
28,108
-2,223
| -7% | -$5.98K |
|
381
Vir Biotechnology
VIR
$1.47B
| $74.1K | ﹤0.01% |
14,698
-1,295
| -8% | -$6.94K |
|
382
Cogent Biosciences
COGT
$6.79B
| $73.3K | ﹤0.01% |
10,205
-5,465
| -35% | -$30.3K |
|
|
DAWN
383
DELISTED
Day One Biopharmaceuticals
DAWN
| $71.4K | ﹤0.01% |
10,988
-148
| -1% | -$1.02K |
|
384
Relay Therapeutics
RLAY
$4.02B
| $70.1K | ﹤0.01% |
20,258
+1,093
| +6% | +$3.25K |
|
385
Kura Oncology
KURA
$922M
| $67.5K | ﹤0.01% |
11,702
-550
| -4% | -$3.37K |
|
386
Myriad Genetics
MYGN
$530M
| $66.8K | ﹤0.01% |
12,575
-1,145
| -8% | -$6.76K |
|
387
Cboe Global Markets
CBOE
$29.8B
| $59.7K | ﹤0.01% |
+256
| New | +$57K |
|
388
Iovance Biotherapeutics
IOVA
$2.23B
| $56K | ﹤0.01% |
32,559
-6,835
| -17% | -$17K |
|
|
NIU
389
Niu Technologies
NIU
$202M
| $53.8K | ﹤0.01% |
+16,000
| New | +$55K |
|
390
Verastem
VSTM
$532M
| $48.6K | ﹤0.01% |
+11,700
| New | +$73.3K |
|
391
Altimmune
ALT
$539M
| $44K | ﹤0.01% |
11,357
-2,070
| -15% | -$11.2K |
|
392
Humacyte
HUMA
$168M
| $43.1K | ﹤0.01% |
20,625
+3,492
| +20% | +$6.71K |
|
|
HUYA
393
Huya Inc
HUYA
$542M
| $36.6K | ﹤0.01% |
+10,399
| New | +$37.7K |
|
394
Taysha Gene Therapies
TSHA
$1.59B
| $30.5K | ﹤0.01% |
+13,214
| New | +$28.7K |
|
395
ACM Research
ACMR
$5.83B
| – | – |
-34,800
| Closed | -$812K |
|
396
Agios Pharmaceuticals
AGIO
$2.16B
| – | – |
-8,750
| Closed | -$256K |
|
397
Akamai
AKAM
$16.8B
| – | – |
-3,049
| Closed | -$245K |
|
398
Aon
AON
$77.3B
| – | – |
-546
| Closed | -$218K |
|
399
argenx
ARGX
$57.4B
| – | – |
-5,800
| Closed | -$3.43M |
|
400
Atour Lifestyle Holdings
ATAT
$4.35B
| – | – |
-48,532
| Closed | -$1.38M |
|
Similar funds
VFCM
DFO
DIA
5NCM
TAM
CS
OAM
QCG
E Fund Management's Q2 2025 Portfolio in Review
As of Q2 2025, E Fund Management held 429 positions worth $2.1B, up 0.21% from $2.09B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
E Fund Management withdrew a net $179M in Q2 2025, closing 35 positions and reducing 267 holdings. Its most notable exit was KE Holdings, an estimated $70.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, E Fund Management opened a new position in Invesco DB Oil Fund worth $11M.
- E Fund Management's largest Q2 2025 buy was Invesco DB Oil Fund: 835,473 shares worth $11M.
- E Fund Management added most to abrdn Physical Gold Shares ETF in Q2 2025, an estimated $19.9M increase.
- E Fund Management's biggest Q2 2025 reduction was Futu Holdings, cutting an estimated $30.9M.
- E Fund Management fully exited KE Holdings in Q2 2025, selling an estimated $70.4M.
- E Fund Management's ten largest holdings make up 52% of its $2.1B portfolio in Q2 2025.
- E Fund Management opened 31 new positions and closed 35 in Q2 2025.
- E Fund Management's portfolio value rose 0.21% quarter-over-quarter to $2.1B.
Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.